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In ischemia condition, 
potassium can restore 
extracellular ion concen-
tration and re-establi-
shes membrane poten-
tial. 
Key factor involved in 
cell-survival pathways.  
• promotes glycolysis  
• reduces FFA in blood 
in ischemia condition.  
• facilitates vascular re-
laxation. 
Glucose is heart pre-
ferring substrate in 
ischemic conditions. 
However hypergly-
caemia could explain 
some failure of  
clinical trials.  
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IR (human INSR) 
Insulin-induced changes activate its phosphorylation 
activity (active site position 1159); it could form with 
IGFR as a hybrid receptor, IR is selectively under 
physiological concentration of insulin (100-500pm). The 
hybrid receptor could be activated under 
supraphysiological concentration.  
IRS 
IRS-proteins (IRS1 and IRS2) have a PTB 
domain at their N-terminus which binds 
specifically to phosphorylated NPXY-motif of 
IR. The C terminus are poorly conserved, 
however contain recognizable tyrosine motifs 
for IR such as YMXM, YVNI and YIDL. 
Phosphorylated-IRS are able to bind 
specifically to SH2 domains of proteins. 
PI3K (human PIK3C) 
PI3K (especially class IA) is a heterodimeric 
lipid kinase composed by a p110 catalytic 
subunit and one p85 regulatory subunit. The 
p85 subunit contains SH2 domain that 
isresponsible for recognition of 
phosphorylated YXXM motif. The 
accumulation of its products PI3,4,5P3 in 
membrane recruits subsequent effectors like 
PDK1, PKB/AKT, etc.  
PDK1 (human PDPK1) 
A Serine/Threonine kinase. PDK1 has two 
domains: a catalytic domain (Asp-205) and the 
PH domain. The PH domain is responsible for 
the phosphatidylinositol lipids-binding 
capacity.  
In response to insulin, PDK1 is recruited and 
then activated by phosphorylation on Tyr-9, 
Tyr-373 and Tyr-376 by IR. Its full activation 
produced when autophosphorylates itself on 
Ser-241.  
 
PKB/AKT  
It is also a serine/thereonine-protein kinase. 
AKT2 isoform is mainly involved in the glucose 
metabolism. AKT2 isoform has got 3 domains: 
a PH domain that gives it the lipid-binding 
ability, a protein kinase domain (active site at 
Asp-275) and a C-terminal AGC-kinase domain. 
 
AKT2  requires phosphorylation on Thr-309 
and Ser-474 for its full activity. After its 
activation, AKT2 phosphorylates a set of 
effectors  
VASCULAR PROTECTION 
In endothelial cells, The insulin-signaling pathway in vascular 
endothelium that regulates activation of eNOS employing a 
phosphorylation-dependent mechanism. 
INTRODUCTION 
Myocardial ischemia is an intermediate stage in coronary artery disease during which the heart tissue is starved of oxygen and nutrients. Eventually, the affected heart tissue can suffer massive 
cell death, occasionally leading to a heart attack when blood flow is completely blocked. 
  
Heart metabolism: 
In normal condition, in heart, FFA is preferred substrate (70%FFA and 30% glucose & lactat), because the β-oxidation of 1 mol palmitate results in more ATP than glucose (129 versus 38 ATP per 1 
mol), but consumes also more oxygen.  
During ischemia, glucose levels are rapidly depleted and FFAs accumulate Increased levels of FFAs depress myocardial contractility, inhibit glycolytic flux, accumulate as myocyte toxic metabolites 
cause membrane damage and arrhythmias, and increase myocardial oxygen consumption without increasing myocardial work.  
  
GIK: Recently it has been shown that necrosis following experimental myocardial ischemia can be reduced by GIK. At 1970, it was established as a possible treatment. Although there are many 
things remain unknown, now a day the GIK clinical uses are having positive effects in some specific cases. 
 
OBJECTIVES 
1. Study about the current status of GIK mix in ACS. 
2. Define the GIK-induced main pathway of cardio protection.  
3. Determination of benefits of GIK in acute myocardial ischemia 
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METHODOLOGY 
This project has  been  made  as  a  scientific  review  using  original  articles  
found  in  PubMed and other scientific. Articles used have been picked up 
considering their abstract, conclusions, concretion into the objective, date of 
publication and quality, as well as if they had been referred in previous articles 
read. Thus, approximately 70 publications have been read, although 50 have been 
finally used in the project writing. 
Heart metabolism and pathway provided by GIK 
Left, Adverse metabolic paths and consequences.  
Right, Beneficial glucose-related metabolic changes.  
TCA: The Citric Acid cycle; ETC: Electron Transport Chain 
ocardial ischemia is an interm diate stage in co onary art ry disease during which the heart tissue is starved of oxyg  and nutrients. Ev n ually, the aff cted heart 
tissue can suffer massive cell death, occasionally leading to a heart attack when blood flow is completely blocked. 
  
In normal condition, in heart, FFA is preferred substrate (70%FFA and 30% glucose & lactate), because the β-oxidation of 1 mol palmitate results in more ATP than 
glucose (129 versus 38 ATP per 1 mol), but consumes also more oxygen. During ischemia, glucose levels are rapidly depleted and FFAs accumulate Increased levels of 
FFAs depress myocardial contractility, inhibit glycolytic flux, accumulate as myocyte toxic metabolites cause membrane damage and arrhythmias, and increase 
myocardial oxygen consumption without reasing myocardial work.  
  
GIK: Recently it has been shown that necrosis following experimental myocardial ischemia can be reduced by GIK. At 1970, it was established as a possible treatment. 
Although there are many things remain unknown, now a day the GIK clinical uses are having positive effects in some specific cases. 
 
CONCLUSION 
Multiple complementary mechanisms may contribute to GIK-related myocardial 
protection: 
1. The shift of the myocardial metabolism from LCFAs to glucose oxidation during 
reperfusion, which is more oxygen efficient and prevents the production of toxic LCFA 
intermediates. 
2. Activated PKB/Akt leads to several protective mechanisms. PKB/Akt phosphorylates, 
sequesters, and/or inactivates several pro-apoptotic proteins including BAD, BAX, and 
caspase-9. 
3. PKB/Akt also phosphorylates and activates eNOS, inducing protection most likely via 
the NO-dependent. 
4. The PKB/Akt/mTOR/ p70S6K is also supposed to be protective by promoting, among 
others, the post-ischaemic synthesis of contractile proteins.  
5. Maintenance of cardiac pH and glucose levels, by affording the necessary substrate 
for ATP formation. 
 
But full metabolic monitoring needs to be performed to definitively prove the beneficial 
effect of GIK infusion. Although the cardio-protective properties of glucose-insulin-
potassium (GIK) remain controversial, in part because of the different contexts, doses, 
timing, and protocol of GIK used in different studies, there is a growing consensus 
supporting the utility of GIK in cardiac surgery and emergency. 
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